H&T PRESSPART OPENS A NEW PLANT FOR PHARMACEUTICAL COMPONENTS IN TARRAGONA
H&T Presspart opened on September 17 the new plant for the production of systems for the administration of drugs and pharmaceutical components in L’Arboç (Tarragona). The president of the Chamber of Commerce of Tarragona Laura Roigé and Kirsty Bourner representing the Glaxo Smith Kline client were present. With this investment, H&T Presspart Tarragona has established itself as a leading manufacturer of inhalers to treat asthma and chronic obstructive pulmonary disease.
Thomas Portune, General Director of H&T Presspart Tarragona, explains the importance of this investment. “We are inaugurating a modern, digital and highly automated factory. Its capable of producing more than 300 Million units of pharmaceutical components per year. This will help improve the lives of patients suffering from lung diseases worldwide. This is great news for our Group and the territory. Today is a day of celebration and we thank our client, our suppliers and our internal teams that have made this project a reality. ”
Our own and third party cookies allow us to improve our services. By browsing this website, you accept our use of them. More information Aceptar
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.